Currently, transvaginal ultrasonography (TVS) and the determination of classical tumor markers—CA125 and/or HE4, alone or in combination with consideration of the patient’s menopausal status in the Risk of Ovarian Malignancy Algorithm (ROMA)—are used in the diagnosis of OC. Here, WFDC2 is linked to neoplasm.